中國武夷(000797.SZ):選舉鄭景昌為董事長、聘任陳平為總經理
格隆匯4月13日丨中國武夷(000797.SZ)公佈,林志英因年齡原因,向公司董事會辭去董事長、董事和董事會戰略委員會委員職務,離任後將不在公司及其控股子公司擔任任何職務。
經公司第七屆董事會第十七次會議審議,選舉鄭景昌擔任公司第七屆董事會董事長,任期和本屆董事會一致。根據《公司章程》規定,公司董事長為公司法定代表人,公司法定代表人將變更為鄭景昌。公司後續將盡快辦理法定代表人工商登記變更手續。
因工作變動原因,公司免去鄭景昌總經理職務,免去陳平副總經理職務,根據公司董事長提名,經公司第七屆董事會第十七次會議審議,聘任陳平為公司總經理,任期和本屆董事會一致。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.